Wuhan BoChuang Automotive Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Wuhan BoChuang Automotive Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 12 (Vehicles) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BOCRAVANT. The owner is based in Wuhan, Hubei.

101, Unit 1, Bldg 11, Zone B, Phase 3,

Ocean World, Jinghe St., Dongxihu Dist.

Wuhan, Hubei 430000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOCRAVANT
BOCRAVANT
Registered 2024

Trademark Classifications

Wuhan BoChuang Automotive Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Wuhan BoChuang Automotive Technology Co., Ltd. have?

Wuhan BoChuang Automotive Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Wuhan BoChuang Automotive Technology Co., Ltd. file in?

Wuhan BoChuang Automotive Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 12 (Vehicles). Class 12 covers vehicles; apparatus for locomotion by land, air or water.

What are Wuhan BoChuang Automotive Technology Co., Ltd.'s most well-known trademarks?

Wuhan BoChuang Automotive Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as BOCRAVANT. These are among 1 currently registered trademark in the portfolio.

What is Wuhan BoChuang Automotive Technology Co., Ltd.'s trademark registration success rate?

Wuhan BoChuang Automotive Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.